Rockwell Medical, Inc.
RMTI
$7.09
$0.253.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.34M | 18.35M | 15.93M | 16.07M | 18.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.34M | 18.35M | 15.93M | 16.07M | 18.91M |
| Cost of Revenue | 14.44M | 14.47M | 13.66M | 13.57M | 15.87M |
| Gross Profit | 2.90M | 3.88M | 2.27M | 2.50M | 3.04M |
| SG&A Expenses | 4.38M | 4.28M | 3.86M | 3.85M | 4.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.82M | 18.74M | 17.51M | 17.42M | 20.27M |
| Operating Income | -1.48M | -398.00K | -1.58M | -1.35M | -1.36M |
| Income Before Tax | -1.61M | -554.00K | -1.75M | -1.49M | -1.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.61M | -554.00K | -1.75M | -1.49M | -1.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.61M | -554.00K | -1.75M | -1.49M | -1.52M |
| EBIT | -1.48M | -398.00K | -1.58M | -1.35M | -1.36M |
| EBITDA | -969.00K | 148.00K | -1.04M | -786.00K | -821.00K |
| EPS Basic | -0.41 | -0.14 | -0.49 | -0.48 | -0.44 |
| Normalized Basic EPS | -0.27 | -0.10 | -0.31 | -0.28 | -0.29 |
| EPS Diluted | -0.41 | -0.15 | -0.50 | -0.50 | -0.44 |
| Normalized Diluted EPS | -0.27 | -0.10 | -0.31 | -0.28 | -0.29 |
| Average Basic Shares Outstanding | 3.94M | 3.94M | 3.60M | 3.43M | 3.41M |
| Average Diluted Shares Outstanding | 3.94M | 3.94M | 3.60M | 3.43M | 3.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |